447 related articles for article (PubMed ID: 31095648)
1. The coronavirus macrodomain is required to prevent PARP-mediated inhibition of virus replication and enhancement of IFN expression.
Grunewald ME; Chen Y; Kuny C; Maejima T; Lease R; Ferraris D; Aikawa M; Sullivan CS; Perlman S; Fehr AR
PLoS Pathog; 2019 May; 15(5):e1007756. PubMed ID: 31095648
[TBL] [Abstract][Full Text] [Related]
2. PARP12 is required to repress the replication of a Mac1 mutant coronavirus in a cell- and tissue-specific manner.
Kerr CM; Parthasarathy S; Schwarting N; O'Connor JJ; Pfannenstiel JJ; Giri E; More S; Orozco RC; Fehr AR
J Virol; 2023 Sep; 97(9):e0088523. PubMed ID: 37695054
[TBL] [Abstract][Full Text] [Related]
3. Viral Macrodomains: Unique Mediators of Viral Replication and Pathogenesis.
Fehr AR; Jankevicius G; Ahel I; Perlman S
Trends Microbiol; 2018 Jul; 26(7):598-610. PubMed ID: 29268982
[TBL] [Abstract][Full Text] [Related]
4. The Conserved Coronavirus Macrodomain Promotes Virulence and Suppresses the Innate Immune Response during Severe Acute Respiratory Syndrome Coronavirus Infection.
Fehr AR; Channappanavar R; Jankevicius G; Fett C; Zhao J; Athmer J; Meyerholz DK; Ahel I; Perlman S
mBio; 2016 Dec; 7(6):. PubMed ID: 27965448
[TBL] [Abstract][Full Text] [Related]
5. Coronavirus infection and PARP expression dysregulate the NAD metabolome: An actionable component of innate immunity.
Heer CD; Sanderson DJ; Voth LS; Alhammad YMO; Schmidt MS; Trammell SAJ; Perlman S; Cohen MS; Fehr AR; Brenner C
J Biol Chem; 2020 Dec; 295(52):17986-17996. PubMed ID: 33051211
[TBL] [Abstract][Full Text] [Related]
6. The Viral Macrodomain Counters Host Antiviral ADP-Ribosylation.
Alhammad YMO; Fehr AR
Viruses; 2020 Mar; 12(4):. PubMed ID: 32244383
[TBL] [Abstract][Full Text] [Related]
7. The SARS-CoV-2 Nsp3 macrodomain reverses PARP9/DTX3L-dependent ADP-ribosylation induced by interferon signaling.
Russo LC; Tomasin R; Matos IA; Manucci AC; Sowa ST; Dale K; Caldecott KW; Lehtiö L; Schechtman D; Meotti FC; Bruni-Cardoso A; Hoch NC
J Biol Chem; 2021 Sep; 297(3):101041. PubMed ID: 34358560
[TBL] [Abstract][Full Text] [Related]
8. PARP12 is required to repress the replication of a Mac1 mutant coronavirus in a cell and tissue specific manner.
Kerr CM; Parthasarathy S; Schwarting N; O'Connor JJ; Giri E; More S; Orozco RC; Fehr AR
bioRxiv; 2023 Jun; ():. PubMed ID: 37398292
[TBL] [Abstract][Full Text] [Related]
9. Host ADP-ribosylation and the SARS-CoV-2 macrodomain.
Hoch NC
Biochem Soc Trans; 2021 Aug; 49(4):1711-1721. PubMed ID: 34351418
[TBL] [Abstract][Full Text] [Related]
10. Identification of Poly(ADP-Ribose) Polymerase Macrodomain Inhibitors Using an AlphaScreen Protocol.
Ekblad T; Verheugd P; Lindgren AE; Nyman T; Elofsson M; Schüler H
SLAS Discov; 2018 Apr; 23(4):353-362. PubMed ID: 29316839
[TBL] [Abstract][Full Text] [Related]
11. Analysis of Coronavirus Temperature-Sensitive Mutants Reveals an Interplay between the Macrodomain and Papain-Like Protease Impacting Replication and Pathogenesis.
Deng X; Mettelman RC; O'Brien A; Thompson JA; O'Brien TE; Baker SC
J Virol; 2019 Jun; 93(12):. PubMed ID: 30918076
[TBL] [Abstract][Full Text] [Related]
12. PARP14 is a PARP with both ADP-ribosyl transferase and hydrolase activities.
Đukić N; Strømland Ø; Elsborg JD; Munnur D; Zhu K; Schuller M; Chatrin C; Kar P; Duma L; Suyari O; Rack JGM; Baretić D; Crudgington DRK; Groslambert J; Fowler G; Wijngaarden S; Prokhorova E; Rehwinkel J; Schüler H; Filippov DV; Sanyal S; Ahel D; Nielsen ML; Smith R; Ahel I
Sci Adv; 2023 Sep; 9(37):eadi2687. PubMed ID: 37703374
[TBL] [Abstract][Full Text] [Related]
13. Crystal structure and biochemical activity of the macrodomain from rubella virus p150.
Stoll GA; Nikolopoulos N; Zhai H; Zhang L; Douse CH; Modis Y
J Virol; 2024 Feb; 98(2):e0177723. PubMed ID: 38289106
[TBL] [Abstract][Full Text] [Related]
14. Interferon-stimulated poly(ADP-Ribose) polymerases are potent inhibitors of cellular translation and virus replication.
Atasheva S; Frolova EI; Frolov I
J Virol; 2014 Feb; 88(4):2116-30. PubMed ID: 24335297
[TBL] [Abstract][Full Text] [Related]
15. Viral macrodomains: a structural and evolutionary assessment of the pharmacological potential.
Rack JGM; Zorzini V; Zhu Z; Schuller M; Ahel D; Ahel I
Open Biol; 2020 Nov; 10(11):200237. PubMed ID: 33202171
[TBL] [Abstract][Full Text] [Related]
16. Chemical genetic methodologies for identifying protein substrates of PARPs.
Rodriguez KM; Cohen MS
Trends Biochem Sci; 2022 May; 47(5):390-402. PubMed ID: 34366182
[TBL] [Abstract][Full Text] [Related]
17. Mono-ADP-ribosylation by PARP10 inhibits Chikungunya virus nsP2 proteolytic activity and viral replication.
Krieg S; Pott F; Potthoff L; Verheirstraeten M; Bütepage M; Golzmann A; Lippok B; Goffinet C; Lüscher B; Korn P
Cell Mol Life Sci; 2023 Feb; 80(3):72. PubMed ID: 36840772
[TBL] [Abstract][Full Text] [Related]
18. Assessment of Intracellular Auto-Modification Levels of ARTD10 Using Mono-ADP-Ribose-Specific Macrodomains 2 and 3 of Murine Artd8.
Bütepage M; Krieg S; Eckei L; Li J; Rossetti G; Verheugd P; Lüscher B
Methods Mol Biol; 2018; 1813():41-63. PubMed ID: 30097860
[TBL] [Abstract][Full Text] [Related]
19. Enabling drug discovery for the PARP protein family through the detection of mono-ADP-ribosylation.
Lu AZ; Abo R; Ren Y; Gui B; Mo JR; Blackwell D; Wigle T; Keilhack H; Niepel M
Biochem Pharmacol; 2019 Sep; 167():97-106. PubMed ID: 31075269
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms governing PARP expression, localization, and activity in cells.
Sanderson DJ; Cohen MS
Crit Rev Biochem Mol Biol; 2020 Dec; 55(6):541-554. PubMed ID: 32962438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
